MSDG May 10 Monthly Meeting – Sponsored by Bruker Daltonics – “Impact of Ultra-High Resolution Mass Spectrometry on Early Stage Developability Assessment”, and “Intact Biotherapeutics Characterization and the Latest in Automated Biopharmaceutical Software – Biopharma Compass 2.0″
I'm honored to have the luxury of leading forward a very successful and impactful section. I would like to thank all our leaders, volunteers, members and community for what they have done to make this section great. I am confident, with such a strong program, we can improve upon this success in 2017.
Read more »✎